On Friday, March 29, 2013 a new medication was approved by the FDA (Food and Drug Administration) for the treatment of type 2 diabetes—Invokana (canaglifozin). Not only is it a new medication, it is also the first in a new class of medications named “sodium-glucose co-transporter 2 inhibitors” or SGLT2. So it works differently than any other medication for diabetes that is currently available.
Invokana works in the kidneys by stopping glucose from being reabsorbed and promotes excretion of the glucose out of the body through the urine. It is to be taken once per day. Not only does it decrease blood glucose levels, but also body weight and blood pressure.
As with any medication, it is not for everyone. And no medication is side effect-free. But it is very exciting that research continues in the field of diabetes! It provides patients and healthcare professionals another option for treatment.
If you would like to read more about this medication, please click on the links below.
Written by: Kathy Haarmann, RN, BSN, CDE